-
COVAX: How Nigeria Received Over 20 Million Doses In Two Years
On the night of Feb. 27, 2020, Nigeria reported its first case of COVID-19 in the country. The case was an Italian citizen who works in Nigeria and returned from Milan, Italy to Lagos, Nigeria on the 25th of February 2020. He was confirmed by the Virology Laboratory of the Lagos University Teaching Hospital, part…
-
Nigeria Received Over 9 million COVID-19 Vaccine In 6 Months
Between March and August, Nigeria has received a total of 9,916,320 doses of Covid-19 vaccines, Twentyten Daily tracked. Within this period, Nigeria received four types of vaccine; Oxford-AstraZeneca, Mordena Vaccine, Johnson and Johnson and Covishield COVID-19 Vaccine. A total of 5,338,640 doses of Oxford-AstraZeneca vaccine was given within the period; 4,000,080 Morderna doses; 177,600 doses…
-
Tanzania Secures Nearly $600M From IMF For COVID Relief
Tanzania would receive $567m from the International Monetary Fund for emergency support to finance a COVID-19 vaccination campaign and meet the health and social costs of the pandemic, according to an IMF statement. The IMF board approved on Tuesday a disbursement of $189m to Tanzania under its Rapid Credit Facility (RCF), as well as $378m…
-
Covid-19: Nigerian Health Centres Lack Capacity To Administer Vaccines
An estimate of 80 percent primary healthcare centres in 15 states of Nigeria lack the capacity to administer COVID-19 vaccines. This is according to a field research conducted by the Connected Development (CODE), a non-governmental organization tracking government’s expenditure.Q Nigeria received 3.92 million doses of AstraZeneca COVID-19 vaccines in March – the first batch of…
-
NAFDAC Approves Johnson & Johnson COVID Vaccine For Emergency use
The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the Johnson & Johnson (J&J) COVID-19 vaccine for immediate emergency use in Nigeria. The announcement was made in a statement issued by Mojisola Adeyeye, director-general of NAFDAC. The J&J vaccine would be the third vaccine to be approved by the country’s drug…
-
Covid-19: Nigeria Reaches One Million Mark in Vaccinations
The National Primary Health Care Development Agency (NPHCDA) has announced that over a million people have received their first doses of the Covid-19 vaccine. Vaccination in Nigeria kicked off on March 5, 2021, with the agency announcing its intent to vaccinate up to 70 percent of the nation’s population. News Agency of Nigeria (NAN) had…
-
COVID-19 Cases, Deaths Increase After 780m Vaccine Doses Administered
The Director-General of the World Health Organisation, Dr Tedros Ghebreyesus, has raised concerns over increasing cases of deaths and confirmed cases of COVID-19 across the globe. He noted that the increasing figures were being recorded despite 780 million doses of vaccine being administered globally. Ghebreyesus spoke at a media briefing on COVID-19 said that the…
-
COVAX: Over 122,000 People Vaccinated In Nigeria
The Federal Government has said that no fewer than 122,410 people have received the AstraZeneca vaccine. While giving updates on the ongoing vaccination across the country, the Executive Director of the National Primary Healthcare Development Agency (NPHCDA), Dr Faisal Shuaib, said, “At this stage, it is important to update Nigerians with the number of vaccinations.…
-
NPHCDA: Over 50% Nigerians Will Take Covid-19 Vaccine
The National Primary Health Care Development Agency has disclosed that over 50 percent of Nigerians have admitted that they will take the Covid-19 vaccines. The agency compared the result to it’s earlier studies which showed that up to 75 percent of Nigerians said they will not take it. NPHCDA CEO, Dr. Faisal Shuaib, said this…
-
Covid-19: Nine Countries Suspend Use Of Oxford-AstraZeneca Vaccine
About nine countries have suspended the use of the Oxford-AstraZeneca covid-19 vaccine after reports of blood clots. The nine countries—Norway, Iceland, Austria, Estonia, Lithuania, Luxembourg, Italy, Latvia and Denmark have temporarily suspended use of the vaccine as a precautionary move after reports of blood clots and one death. The decisions are a setback for Europe’s…